Cargando…

Staphyloxanthin: a potential target for antivirulence therapy

Staphylococcus aureus is an important and common Gram-positive bacteria which causes clinical infections and food-poisoning cases. Therapeutic schedules for treatment of S. aureus infections are facing a challenge because of the emergence of multidrug resistance strains. It is urgent to find new ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Lijun, Chen, Yang Yizhi, Yan, Zhiyun, Lu, Wei, Wan, Dong, Zhu, Huifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647007/ https://www.ncbi.nlm.nih.gov/pubmed/31410034 http://dx.doi.org/10.2147/IDR.S193649

Ejemplares similares

Staphyloxanthin as a Potential Novel Target for Deciphering Promising Anti-Staphylococcus aureus Agents
por: Elmesseri, Rana A., et al.
Publicado: (2022)

Photolysis of Staphyloxanthin in Methicillin‐Resistant Staphylococcus aureus Potentiates Killing by Reactive Oxygen Species
por: Dong, Pu‐Ting, et al.
Publicado: (2019)

Quorum Quenching Agents: Resources for Antivirulence Therapy
por: Tang, Kaihao, et al.
Publicado: (2014)

Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens
por: Scoffone, Viola Camilla, et al.
Publicado: (2019)

Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies
por: Askoura, Momen, et al.
Publicado: (2022)

Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus
por: Abbas, Hisham A, et al.
Publicado: (2019)

Impact of Deficiencies in Branched-Chain Fatty Acids and Staphyloxanthin in Staphylococcus aureus
por: Braungardt, Hannah, et al.
Publicado: (2019)

Identification of staphyloxanthin and derivates in yellow-pigmented Staphylococcus capitis subsp. capitis
por: Siems, Katharina, et al.
Publicado: (2023)

SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
por: Gao, Peng, et al.
Publicado: (2023)

Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus
por: Elmesseri, Rana A., et al.
Publicado: (2023)

Virulence Determinants Are Required for Brain Abscess Formation Through Staphylococcus aureus Infection and Are Potential Targets of Antivirulence Factor Therapy
por: Zheng, Ying, et al.
Publicado: (2019)

Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics
por: Sintchenko, Vitali, et al.
Publicado: (2021)

A Very Early-Branching Staphylococcus aureus Lineage Lacking the Carotenoid Pigment Staphyloxanthin
por: Holt, Deborah C., et al.
Publicado: (2011)

NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
por: Fenn, Samuel, et al.
Publicado: (2021)

The arsenal of pathogens and antivirulence therapeutic strategies for disarming them
por: Brannon, John R, et al.
Publicado: (2016)

Tamarindus indica Extract as a Promising Antimicrobial and Antivirulence Therapy
por: Ghaly, Mohamed F., et al.
Publicado: (2023)

Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach
por: Yehia, Fatma Al-zahraa A., et al.
Publicado: (2022)

Antivirulence Activity of the Human Gut Metabolome
por: Antunes, L. Caetano M., et al.
Publicado: (2014)

Antivirulence activity of azithromycin in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2014)

Editorial: Antivirulence Drugs Against Bacterial Infections
por: Imperi, Francesco, et al.
Publicado: (2021)

Interrelationships among Fatty Acid Composition, Staphyloxanthin Content, Fluidity, and Carbon Flow in the Staphylococcus aureus Membrane
por: Tiwari, Kiran B., et al.
Publicado: (2018)

Variable staphyloxanthin production by Staphylococcus aureus drives strain-dependent effects on diabetic wound-healing outcomes
por: Campbell, Amy E., et al.
Publicado: (2023)

Campylobacter sp.: Pathogenicity factors and prevention methods—new molecular targets for innovative antivirulence drugs?
por: Kreling, Vanessa, et al.
Publicado: (2020)

Correction: Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach
por: Yehia, Fatma Al-zahraa A., et al.
Publicado: (2022)

Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections
por: Calvert, Matthew B, et al.
Publicado: (2018)

African Plant-Based Natural Products with Antivirulence Activities to the Rescue of Antibiotics
por: Mahavy, Christian Emmanuel, et al.
Publicado: (2020)

Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development
por: Lau, Wing Yin Venus, et al.
Publicado: (2023)

QseC Inhibitors as an Antivirulence Approach for Gram-Negative Pathogens
por: Curtis, Meredith M., et al.
Publicado: (2014)

Antivirulence and avirulence genes in human pathogenic fungi
por: Siscar-Lewin, Sofía, et al.
Publicado: (2019)

Factors Determining Staphylococcus aureus Susceptibility to Photoantimicrobial Chemotherapy: RsbU Activity, Staphyloxanthin Level, and Membrane Fluidity
por: Kossakowska-Zwierucho, Monika, et al.
Publicado: (2016)

Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus
por: Arya, Rekha, et al.
Publicado: (2023)

Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii
por: Hetta, Helal F., et al.
Publicado: (2021)

Carvacrol Targets SarA and CrtM of Methicillin-Resistant Staphylococcus aureus to Mitigate Biofilm Formation and Staphyloxanthin Synthesis: An In Vitro and In Vivo Approach
por: Selvaraj, Anthonymuthu, et al.
Publicado: (2020)

Controlling foodborne pathogens with natural antimicrobials by biological control and antivirulence strategies
por: Abdelhamid, Ahmed G., et al.
Publicado: (2020)

Uncharted territories in the discovery of antifungal and antivirulence natural products from bacteria
por: Vij, Raghav, et al.
Publicado: (2021)

Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era
por: Neville, Nolan, et al.
Publicado: (2019)

Small-molecule compound SYG-180-2-2 attenuates Staphylococcus aureus virulence by inhibiting hemolysin and staphyloxanthin production
por: Rao, Lulin, et al.
Publicado: (2022)

The Sociomicrobiology of Antivirulence Drug Resistance: a Proof of Concept
por: Mellbye, Brett, et al.
Publicado: (2011)

Antibiofilm and Antivirulence Properties of Indoles Against Serratia marcescens
por: Sethupathy, Sivasamy, et al.
Publicado: (2020)

High-Throughput Approaches for the Identification of Pseudomonas aeruginosa Antivirulents
por: Kang, Donghoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5vcgu8r1ks4849niv4aavo4on